Study of the Mechanisms of Action of Cladribine in Multiple Sclerosis
NCT04821596
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
77
Enrollment
OTHER
Sponsor class
Conditions
Multiple Sclerosis
Interventions
OTHER:
biological collection
Sponsor
University Hospital, Rouen